Philadelphia: Biotech Strategy Blog is in Philadelphia for the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference (aka known as ‘The Triple’) that starts today and goes on over the weekend until Monday.
Molecular Targets has always been one of my favourite meetings!
Coming here is a reminder that despite the excitement and promise of immunotherapy, there is a lot still happening in cancer research on targeted therapies, as well as the intersection of the two. I expect many of the thought leaders here to be talking about the challenge of how do we combine targeted therapy with immmunotherapy to best effect.
I don’t think there will be much on social media since much of the work discussed here is unpublished and we don’t tweet that, but if you do want to follow along, the Twitter hashtag is the memorable #Targets17. There’s also an app you can download to see the full program etc.
For BSB subscribers, over the weekend we’ll be providing a daily summary post at the end of each day on key topics, issues, and themes we’ve picked up during the meeting.
Today, there was a press conference at 9.15am with the three meeting co-chairs:
What did Drs Ribas, Gulley and Swanton have to say about what we can expect from the meeting and some of the key themes and noteworthy abstracts presented?
Stay tuned for more!
To learn more insights on this intriguing topic, subscribers can log-in or you can click to gain access to BSB Premium Content.
As those of you who have been following my conference schedule already know, I will be at Health Journalism 2011 in Philadelphia later this week. The annual meeting of the Association of Health Care Journalists (AHCJ) runs from April 14-17.
It’s my first time at an AHCJ conference, and in my first video blog post I have shared why I am going and what I hope to obtain from the meeting.
Some of the expert sessions that I am particularly looking forward to are on:
Spotting fraud in scientific research (moderated by Ivan Oransky, M.D. executive editor, Reuters Health; blogger, Retraction Watch and Embargo Watch)
Efforts to revive the drug delivery pipeline (moderated by Ed Silverman, editor-at-large, Med Ad News and R&D Directions)
Understanding nanotechnology’s role in fighting cancer (moderated by Eric Rosenthal, special correspondent, Oncology Times)
Best practices in blogging and social media (moderated by Scott Hensley, health blog writer and editor, National Public Radio)
As William Heisel states in an excellent blog post on Reporting on Health, the journalism stars have come out for ACHJ Health Journalism conference in Philadelphia. I am looking forward to an exciting and informative meeting. Hope to see you there.